St George's Cancer Care Centre Becomes First Elekta Unity Site to Integrate ClearCalc

St George’s is the first cancer center in the world to leverage ClearCalc with Elekta’s MR-Linac technology.

Radformation, a leading innovator in automation solutions for radiation oncology, is delighted to announce that St George's Cancer Care Centre, located in Christchurch, New Zealand, has become the first Elekta Unity MR-Linac site in the world to implement ClearCalc, Radformation's independent secondary dose calculation software. This ground-breaking integration marks a significant advancement in precision medicine and reinforces St George's Cancer Care Centre’s commitment to delivering exceptional patient-centric radiation therapy.

ClearCalc is a critical tool that provides the accurate quality assurance necessary to prevent treatment errors in the radiation oncology workflow. Designed with state-of-the-art algorithms and a user-friendly interface, ClearCalc empowers clinicians to optimize treatment plans while reducing complexity and time-consuming manual calculations. By seamlessly integrating ClearCalc into their Elekta Unity system, St George's further enhances its ability to deliver personalized, high-quality, MRgRT-guided radiation therapy to patients with unparalleled precision.

"We are proud to be the first Elekta Unity site in the world to introduce ClearCalc," said Dr. Jerome Gastaldo, Chief Medical Physicist at St George's Cancer Care Centre. "At our institution, patient well-being and treatment efficacy are our top priorities. ClearCalc's remarkable accuracy and efficiency empower our multidisciplinary team to streamline treatment planning, minimize uncertainties, and ultimately improve outcomes for our patients."

"We are delighted to collaborate with St George's Cancer Care Centre and support their mission of advancing cancer care," stated Joe Ianni, VP of Global Sales & Strategic Partnerships at Radformation. "ClearCalc's integration into the Elekta Unity system at St George's marks an important step towards equipping clinicians worldwide with solutions to deliver personalized, efficient, and precise cancer care. We are confident that ClearCalc's implementation will further cement St George's Cancer Care Centre’s reputation as a pioneer in state-of-the-art radiation therapy."

The collaboration between Radformation and St George's Cancer Care Centre exemplifies the shared commitment to improving patient outcomes through innovative solutions.

About Radformation

Radformation is committed to improving clinicians’ lives by delivering user-friendly products developed to increase cancer treatments’ safety and quality. Radformation envisions a radiation oncology clinic where staff is armed with solutions that supplement their expertise and automate tedious tasks, leading to better patient care everywhere. Since 2016 Radformation has grown to serve over 1,400 clinics worldwide with a portfolio of products streamlining all stages of the treatment planning workflow. For more information, visit radformation.com.

About St George's Cancer Care Centre

St George's Cancer Care Centre is a centre of excellence renowned for its commitment to excellence in patient care, cutting-edge technology, and continuous innovation. The Centre prides itself on being the patients’ choice for world-class cancer treatment. With cutting-edge technology and decades of experience in cancer treatment, St George’s Cancer Care Centre goes above and beyond to provide innovative clinical care with patients at the centre of everything they do. For more information, visit stgeorgescancercarecentre.org.nz.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.73
+3.58 (1.78%)
AAPL  263.86
-0.02 (-0.01%)
AMD  199.22
-3.87 (-1.90%)
BAC  53.25
+0.51 (0.97%)
GOOG  303.46
+0.64 (0.21%)
META  638.94
-0.35 (-0.05%)
MSFT  400.50
+3.64 (0.92%)
NVDA  187.92
+2.95 (1.60%)
ORCL  156.13
+2.16 (1.40%)
TSLA  411.39
+0.76 (0.19%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.